In 2025, clients turned to our firm for guidance on many of their most significant and transformative M&A transactions. Our team advised on deals of every size and level of complexity—from venture‑backed exits and reverse mergers to private equity investments and strategic acquisitions—across key industries including life sciences, energy, technology, healthcare, cannabis and natural resources.
As we look ahead to 2026, we are closely monitoring several themes shaping the dealmaking environment:
- M&A (Measured) Optimism
Dealmakers are entering 2026 with cautious but measured optimism, anticipating modest increases in deal volume and value, supported by rate cuts and resilient equity markets, even as inflation, unemployment trends, and tariff uncertainty create headwinds. - Private Equity
Private equity activity is regaining momentum as sponsors transition from triage to execution, backed by a lower cost of capital, stronger operating fundamentals, and increasing pressure to pursue exits and advance middle‑market platform acquisitions. - Deal Architecture
Transaction structures continue to grow more sophisticated, with earnouts, vendor notes, larger rollover stakes, and enhanced covenants and representations becoming key tools for bridging valuation gaps and navigating heightened regulatory and cybersecurity scrutiny.
We are proud to showcase a selection of our clients' 2025 M&A matters and remain committed to supporting their strategic objectives in the year ahead.
View our full Mergers & Acquisitions: 2025 Deal Highlights, including key highlights and our perspectives on the trends shaping 2026.